Fentanyl test strips are saving lives, but that's just the beginning.

Published Date: 16 Feb 2023

Abbott has previously opposed legislation to test strips, but noted an 89% increase in fentanyl deaths in Texas over the past year.

Read Full News

Latest News

DEA Targets Synthetic 7-OH Products With Schedule I Proposal

The DEA’s proposal would classify concentrated synthetic 7-OH products as Schedule I drugs, while leaving most botanical kratom outside the ban.

Which Factors Are Driving Older Canadians to the ED?

In Canada, ED overcrowding, particularly with older adults, is a healthcare system failure that must be addressed across disciplines, and with government support, experts say.

Most Childhood Headaches Remain Unclassified in Primary Care

Most cases of headache among children and adolescents in primary care remain unclassified, and many are prescribed acute medication.

Elderly Woman Survives Deadly Injury

The penetrating wound occurred doing pool maintenance

From Syria to Deliberate Pyridostigmine Overdose

Keeping one tragedy from begetting another

Ovarian Cancer Frequently Diagnosed Only After Hospital Admission

— Post-admission diagnoses three times as likely to be advanced-stage at recognition

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Todays Updates

Buprenorphine XR Injections Cut 'Need-Based' Opioid Craving

Extended-release buprenorphine injections increase the number of opioid-free days primarily via direct pathways and by suppressing need-related craving, a causal mediation analysis shows.

Fatty Pancreas Linked to Risk for T2D and CKD

Moderate-to-severe fatty pancreas is independently linked to a higher risk for incident type 2 diabetes and chronic kidney disease.

Latest News

The DEA’s proposal would classify concentrated synthetic 7-OH products as Schedule I drugs, while leaving most botanical kratom outside the ban.

In Canada, ED overcrowding, particularly with older adults, is a healthcare system failure that must be addressed across disciplines, and with government support, experts say.

Most cases of headache among children and adolescents in primary care remain unclassified, and many are prescribed acute medication.

The penetrating wound occurred doing pool maintenance

Keeping one tragedy from begetting another

— Post-admission diagnoses three times as likely to be advanced-stage at recognition

News All Time

The World Cup Is Coming. Here’s What EDs Should Prepare For.

Heat, cardiac events, behavioral health, security threats, and infectious disease are all at play

What Caused Boy in Rural Area to Develop High Fever and Hemoptysis?

Rural life has its hazards, as clinicians in China explain

ACEP President: Emergency Medicine Is Here to Stay

Claims that EDs are too costly and overused miss the mark

The Case Against Calling It 'Emergency Medicine'

The misnomer legitimizes overutilization and may be causing harm

Hospitals Are Using AI to Detect Intimate Partner Violence. That's a Problem.

Survivors should decide when they share and with whom

Where the World Cup, Homelessness, and the ED Meet

— Will newfound investments in housing become permanent features of healthier communities?

Cheerleading Head Injuries Declined After 2012 Rule Change

Cheerleading-related head injury rates have earned comparisons to football

NHS Extends RSV Jab to At-Risk Adults Aged 65-74

All adults aged 65-74 with a chronic respiratory condition or a weakened immune system will be offered the RSV vaccine from September, NHS England has confirmed.

Cannibalism Is Bad for Your Health, Scientists Find

Cannibalism became taboo in human societies not out of instinctive aversion but because it is ⁠harmful to populations who practise it, scientists from Poland and the Czech...

Psychiatric Screening in the ED Lacks High-Quality Evidence

Medical screening of adult patients with psychiatric complaints in the emergency department varies widely, and evidence supporting routine testing is limited, a review shows.

How to Recognize Serious Pediatric Pain

Experts highlighted the warning signs that can help clinicians distinguish common pediatric pain from potentially serious underlying disease.

Modifiable Factors Responsible for Most Epilepsy Relapses

In patients with newly diagnosed epilepsy, nearly 70% of seizure relapses are linked to potentially modifiable factors, including poor adherence and inadequate ASM dosing, rather than drug resistance.

Do Longer ED Shifts Lead to More Medication Errors?

Pharmacist interventions on emergency department medication orders are more likely to increase with an increase in the time spent on shift by clinicians, a study finds.

The Other Doctor in the Emergency Department: AI

In emergency departments across the country, AI is quietly joining the diagnostic process.

Could Sleep Apnea Improvements Persist After Therapy?

A Spanish trial finds positional therapy improves positional sleep apnea, is better tolerated than CPAP, and maintains benefits in many patients after treatment ends.

Combination Therapy Outperforms Haloperidol for Agitation

Antipsychotic-benzodiazepine combinations outperform haloperidol alone for rapid sedation in patients with psychomotor agitation, new research shows.

Recommended News For You

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

When it comes to obesity-related cancers, where you shop for food matters

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

Immunotherapy Remains Little Used in Head and Neck Cancer

Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety

A consensus statement from researchers on the proper use of Lu-177 PSMA-617 radionuclide therapy and patient selection is published.

Recommended Articles For You

Cancer Rates on the Rise: What Can We Do to Stop It? 

Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers 

Comprehensive Applications in Oncology and Quality Improvement 

Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combination Treatment May Improve Multiple Myeloma Outcomes

2.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

3.

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

4.

Mortality up for children with leukemia from lowest SES neighborhoods

5.

WHO launches plan for free child cancer medicines

1.

Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance

2.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

3.

Evidence-Based Pathways for Survivorship Care Planning

4.

Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial

5.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Navigating the Complexities of Ph Negative ALL - Part XIV

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V

4.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

5.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot